Skip to content

Study on the analgesic effect of transvaginal four-dimensional ultrasound in tubal ultrasonography

The analgesic value of local anesthetic lidocaine in four-dimensional tubal contrast-enhanced ultrasonography in infertile patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014489
Enrollment
Unknown
Registered
2018-01-16
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

control group:Vitamin C Tablets
Atropine group:Atropine

Sponsors

Jiangsu Province Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. clinical diagnosis of infertility patients (edited by Le Jie "obstetrics and Gynecology" normal sexual life without contraception for 1 years before pregnancy; a woman who has never pregnancy for primary infertility, pregnancy and then had no contraception for 1 years without pregnancy for secondary infertility) in the treatment of our hospital, to four-dimensional tubal ultrasound contrast examination; 2. Aged 18~45 year women experienced sexual life; 3. informed consent voluntary test. The process of obtaining informed consent shall comply with the provisions of GCP.

Exclusion criteria

Exclusion criteria: 1. acute pelvic inflammatory disease, authors; 2. have serious primary heart, liver, lung, kidney, blood or the serious disease that affects its existence; 3. epileptic patients, or because of mental or behavioral disorders, do not give full informed consent; 4. suspected or indeed a history of alcohol or substance abuse; 5. according to the researcher's judgment, the possibility of reducing the possibility of entering a group or complicating other complications, such as frequent changes in the work environment, easily lead to lost access; 6. allergies, such as those who have allergies to two or more drugs or foods; or are known to be allergic to the ingredients; 7. patients who are participating in other clinical trials of drugs; 8. patients with infectious diseases.

Design outcomes

Primary

MeasureTime frame
Pain score 1;Pain score 2;Pain score 3;Pain score 4;tubal were unobstructed;tubal were partially obstructed;tubal were completely obstructed;

Countries

China

Contacts

Public ContactYunfei Ma

Department of Ultrasound, Province Hospital of Traditional Chinese Medicine

439925904@qq.com+86 13851420231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026